CADOR
Live / Registered — Cancelled — Section 71 (as of 26 Feb 2021)
What this means for you
Registered since 05 May 2009. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79054583
- Registration number
- 3616297
- Mark type
- Stylized text
- Filed
- 18 Mar 2008
- Published for opposition
- 17 Feb 2009
- Registered
- 05 May 2009
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological products for industrial and scientific purposes and laboratory analysis, namely, buffers, solvents, and natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, and macromolecules; chemical reagents and solvents for non medical purposes, namely, for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, purification, amplification and/or analysis of natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; kits for research purposes comprising chemical products, namely, reagents and solvents for sample preparation, modification and manipulation of samples and cells as well as for labeling, separating, isolating, purifying, amplifying and/or analyzing natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, namely, nucleic acids and oligonucleotides from biological or biochemical sample material
- Class 005 — Pharmaceuticals: [ Pharmaceutical and veterinary medical products, namely, buffers, solvents, oligonucleotides, proteins, macromolecules and biologically active substances; products for healthcare purposes, namely, buffers, solvents, oligonucleotides, proteins, macromolecules and biologically active substances; ] diagnostic preparations for medical or veterinary use; products for medical or veterinary medical purposes, namely, diagnostic preparations used for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, purification, amplification and/or analysis of natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products for medical or veterinary purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells as well as for labeling, separating, isolating, purifying, amplifying and/or analyzing natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances for diagnostic purposes; in vitro diagnostic preparations for medical purposes; kits comprising products, namely, reagents and solvents for medical and/or veterinary medical diagnostic purposes, namely, for sample preparation, modification and manipulation of cells as well as for labeling, separating, isolating, purifying, amplifying and/or analyzing natural or synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, namely, nucleic acids and oligonucleotides from biological or biochemical sample material; all purpose disinfectants
Owner
- QIAGEN Leipzig GmbH, DE
- QIAGEN GmbH, Hilden, DE
- QIAGEN GmbH, DE
- QIAGEN GmbH, DE
Prosecution history
- 14 Jan 2022 — TOTAL INVALIDATION PROCESSED BY THE IB
- 16 Dec 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 16 Dec 2021 — INVALIDATION PROCESSED
- 26 Oct 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Feb 2021 — CANCELLED SECTION 71
- 05 Oct 2018 — CHANGE OF OWNER RECEIVED FROM IB
- 05 May 2018 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 05 Apr 2018 — INTERNATIONAL REGISTRATION RENEWED
- 28 Apr 2015 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 28 Apr 2015 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 28 Apr 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Apr 2015 — TEAS SECTION 71 & 15 RECEIVED
- 13 Jan 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Aug 2009 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Aug 2009 — FINAL DISPOSITION PROCESSED